RT Journal Article SR Electronic T1 Dominant Clade-featured SARS-CoV-2 Co-occurring Mutations Reveals Plausible Epistasis: An in silico based Hypothetical Model JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2021.02.21.21252137 DO 10.1101/2021.02.21.21252137 A1 Alam, A. S. M. Rubayet Ul A1 Islam, Ovinu Kibria A1 Hasan, Md. Shazid A1 Islam, Mir Raihanul A1 Mahmud, Shafi A1 Al□Emran, Hassan M. A1 Jahid, Iqbal Kabir A1 Crandall, Keith A. A1 Hossain, M. Anwar YR 2021 UL http://medrxiv.org/content/early/2021/07/16/2021.02.21.21252137.abstract AB SARS-CoV-2 is evolved into eight fundamental clades where four (G, GH, GR, and GV) are globally prevalent in 2020. How the featured co-occurring mutations of these clades are linked with viral fitness is the main question here and we thus proposed a hypothetical model using in silico approach to explain the plausible epistatic effects of those mutations on viral replication and transmission. Molecular docking and dynamics analyses showed the higher infectiousness of a spike mutant through more favorable binding of G614 with the elastase-2. RdRp mutation p.P323L significantly increased genome-wide mutations (p<0.0001) since more flexible RdRp (mutated)-NSP8 interaction may accelerate replication. Superior RNA stability and structural variation at NSP3:C241T might impact protein and/or RNA interactions. Another silent 5’UTR:C241T mutation might affect translational efficiency and viral packaging. These four G-clade-featured co-occurring mutations might increase viral replication. Sentinel GH-clade ORF3a:p.Q57H constricted ion-channel through inter-transmembrane-domain interaction of cysteine(C81)-histidine(H57) and GR-clade N:p.RG203-204KR would stabilize RNA interaction by a more flexible and hypo-phosphorylated SR-rich region. GV-clade viruses seemingly gained the evolutionary advantage of the confounding factors; nevertheless, N:p.A220V might modulate RNA binding with no phenotypic effect. Our hypothetical model needs further retrospective and prospective studies to understand detailed molecular events featuring the fitness of SARS-CoV-2.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe get no funds to carry out this research workAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Our University (Jashore University of Science and Technology) has provided ethical permission to do the work. However, this is a dry lab work.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the sequence data were taken from the GISAID (https://www.gisaid.org/) and RCSB PDB (https://www.rcsb.org/) as mentioned in the methodology section. We provide all the necessary information such as accession numbers, date-based data source for helping readers and reviewers to check the authencity of the work. https://www.gisaid.org/